Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Equity Income (2019 - 2024)

Viemed Healthcare's Equity Income history spans 6 years, with the latest figure at $96000.0 for Q3 2024.

  • For Q3 2024, Equity Income fell 64.44% year-over-year to $96000.0; the TTM value through Jun 2025 reached $96000.0, up 113.03%, while the annual FY2024 figure was -$954000.0, 296.7% down from the prior year.
  • Equity Income reached $96000.0 in Q3 2024 per VMD's latest filing, up from -$1.1 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $459000.0 in Q4 2021 to a low of -$1.1 million in Q2 2024.
  • Average Equity Income over 5 years is $94631.6, with a median of $84000.0 recorded in 2022.
  • Peak YoY movement for Equity Income: skyrocketed 1476.19% in 2021, then tumbled 915.33% in 2024.
  • A 5-year view of Equity Income shows it stood at $55000.0 in 2020, then skyrocketed by 734.55% to $459000.0 in 2021, then crashed by 82.14% to $82000.0 in 2022, then tumbled by 47.56% to $43000.0 in 2023, then surged by 123.26% to $96000.0 in 2024.
  • Per Business Quant, the three most recent readings for VMD's Equity Income are $96000.0 (Q3 2024), -$1.1 million (Q2 2024), and $67000.0 (Q1 2024).